Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis

By sjmartinez • May 15, 2025

Armstrong AW, Blauvelt A, Lebwohl M, Asahina A, Gogineni R, Griffiths CEM. Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis. Br J Dermatol. 2025 May 14:ljaf171. doi: 10.1093/bjd/ljaf171. Epub ahead of print. PMID: 40365708.

Tags: Dermatology, Publications

Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides

Qin M, Evron E, Tran PT, Deng M, Nelson AM, Kim J, Agak GW. Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides.[...]

Frailty in lung transplant recipients is associated with anemia and telomere dysfunction but independent of epigenetic age

Kapse B, Mohanty RP, Wax M, Gao Y, Tran L, Wolters PJ, Pellegrini M, Singer JP, Greenland JR. Frailty in lung transplant recipients is associated[...]

Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection

Yan MJ, Phan H, Hsu S, Kang Y, Yu Y. Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection. Cureus. 2025 Apr[...]